Anti-cisplatin-induced Renal-injury Effect of Human Manganese Superoxide Dismutase with Leader Peptide

Objective To investigate the effect of the fusion of leader peptide on the structure of human manganese superoxide dismutase (SOD2) and anti-cisplatin (DDP)-induced renal injury. Methods The effect of mitochondrion targeting sequence (MTS) on the structure and activity of SOD2 was analyzed by struct...

Full description

Bibliographic Details
Main Authors: PAN Jianru, HAN Ya'nan, HE Xiaqi, YE Xiaoqiang, HE Huocong
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2023-07-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1465
_version_ 1797737749075197952
author PAN Jianru
HAN Ya'nan
HE Xiaqi
YE Xiaoqiang
HE Huocong
author_facet PAN Jianru
HAN Ya'nan
HE Xiaqi
YE Xiaoqiang
HE Huocong
author_sort PAN Jianru
collection DOAJ
description Objective To investigate the effect of the fusion of leader peptide on the structure of human manganese superoxide dismutase (SOD2) and anti-cisplatin (DDP)-induced renal injury. Methods The effect of mitochondrion targeting sequence (MTS) on the structure and activity of SOD2 was analyzed by structure prediction and superoxide dismutase (SOD) specific-activity determination. The DDP injury model of Kunming (KM) mice was established, and amifostine (AMFT) was set as a positive control. Indicators such as kidney index, renal function, kidney antioxidant capacity, and appearance and pathology changes of mice kidney were used to evaluate the effect of MTS-SOD2 against DDP-induced kidney injury. Results The MTS leader peptide seemed to change the secondary and tertiary structures of SOD2 to some extent, but it also increased the specific activity of the MTS-SOD2 protein. Pre-administration of a medium dose of MTS-SOD2 (0.84 mg/kg) before the use of DDP significantly reduced the level of renal malondialdehyde and increased the SOD activity and total antioxidant capacity (T-AOC) in the kidney, thereby reducing the renal pathological damage and consequently maintaining renal function. The overall protective effect of MTS-SOD2 was comparable to or even better than that of 200 mg/kg AMFT. Conclusion The MTS leader peptide enhances the activity of SOD2 and confers it with an excellent anti-DDP-induced renal-injury effect because of its transmembrane function.
first_indexed 2024-03-12T13:32:55Z
format Article
id doaj.art-f51bfd7b9e284603b9544c5e4b52c0b0
institution Directory Open Access Journal
issn 1000-8578
language zho
last_indexed 2024-03-12T13:32:55Z
publishDate 2023-07-01
publisher Magazine House of Cancer Research on Prevention and Treatment
record_format Article
series Zhongliu Fangzhi Yanjiu
spelling doaj.art-f51bfd7b9e284603b9544c5e4b52c0b02023-08-24T06:55:31ZzhoMagazine House of Cancer Research on Prevention and TreatmentZhongliu Fangzhi Yanjiu1000-85782023-07-0150767568010.3971/j.issn.1000-8578.2023.22.14658578.2023.22.1465Anti-cisplatin-induced Renal-injury Effect of Human Manganese Superoxide Dismutase with Leader PeptidePAN Jianru0HAN Ya'nan1HE Xiaqi2YE Xiaoqiang3HE Huocong4College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, ChinaCollege of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, ChinaCollege of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, ChinaCollege of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, ChinaLaboratory of Radiation Biology, Clinical Oncology School of Fujian Medical University & Fujian Cancer Hospital, Fuzhou 350014, ChinaObjective To investigate the effect of the fusion of leader peptide on the structure of human manganese superoxide dismutase (SOD2) and anti-cisplatin (DDP)-induced renal injury. Methods The effect of mitochondrion targeting sequence (MTS) on the structure and activity of SOD2 was analyzed by structure prediction and superoxide dismutase (SOD) specific-activity determination. The DDP injury model of Kunming (KM) mice was established, and amifostine (AMFT) was set as a positive control. Indicators such as kidney index, renal function, kidney antioxidant capacity, and appearance and pathology changes of mice kidney were used to evaluate the effect of MTS-SOD2 against DDP-induced kidney injury. Results The MTS leader peptide seemed to change the secondary and tertiary structures of SOD2 to some extent, but it also increased the specific activity of the MTS-SOD2 protein. Pre-administration of a medium dose of MTS-SOD2 (0.84 mg/kg) before the use of DDP significantly reduced the level of renal malondialdehyde and increased the SOD activity and total antioxidant capacity (T-AOC) in the kidney, thereby reducing the renal pathological damage and consequently maintaining renal function. The overall protective effect of MTS-SOD2 was comparable to or even better than that of 200 mg/kg AMFT. Conclusion The MTS leader peptide enhances the activity of SOD2 and confers it with an excellent anti-DDP-induced renal-injury effect because of its transmembrane function.http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1465manganese superoxide dismutaseleader peptidecisplatinrenal injury
spellingShingle PAN Jianru
HAN Ya'nan
HE Xiaqi
YE Xiaoqiang
HE Huocong
Anti-cisplatin-induced Renal-injury Effect of Human Manganese Superoxide Dismutase with Leader Peptide
Zhongliu Fangzhi Yanjiu
manganese superoxide dismutase
leader peptide
cisplatin
renal injury
title Anti-cisplatin-induced Renal-injury Effect of Human Manganese Superoxide Dismutase with Leader Peptide
title_full Anti-cisplatin-induced Renal-injury Effect of Human Manganese Superoxide Dismutase with Leader Peptide
title_fullStr Anti-cisplatin-induced Renal-injury Effect of Human Manganese Superoxide Dismutase with Leader Peptide
title_full_unstemmed Anti-cisplatin-induced Renal-injury Effect of Human Manganese Superoxide Dismutase with Leader Peptide
title_short Anti-cisplatin-induced Renal-injury Effect of Human Manganese Superoxide Dismutase with Leader Peptide
title_sort anti cisplatin induced renal injury effect of human manganese superoxide dismutase with leader peptide
topic manganese superoxide dismutase
leader peptide
cisplatin
renal injury
url http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1465
work_keys_str_mv AT panjianru anticisplatininducedrenalinjuryeffectofhumanmanganesesuperoxidedismutasewithleaderpeptide
AT hanyanan anticisplatininducedrenalinjuryeffectofhumanmanganesesuperoxidedismutasewithleaderpeptide
AT hexiaqi anticisplatininducedrenalinjuryeffectofhumanmanganesesuperoxidedismutasewithleaderpeptide
AT yexiaoqiang anticisplatininducedrenalinjuryeffectofhumanmanganesesuperoxidedismutasewithleaderpeptide
AT hehuocong anticisplatininducedrenalinjuryeffectofhumanmanganesesuperoxidedismutasewithleaderpeptide